Related Experiment Video
Updated: Aug 8, 2025
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Familial Primary Biliary Cholangitis With Different Clinical Courses Based on Anti-gp210 Antibody Positivity: A
Takahiro Nagata1, Yasuaki Takeyama1, Satoshi Shakado1
1Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Fukuoka, JPN.
Insights
Anti-glycoprotein 210 (anti-gp210) antibody positivity may indicate a poorer prognosis in primary biliary cholangitis (PBC) patients, even within families. This finding highlights the role of specific antibodies in PBC progression.
Area of Science:
- Hepatology
- Immunology
- Genetics
Background:
- Primary biliary cholangitis (PBC) is a chronic liver disease often associated with autoimmune conditions.
- Overlap syndrome of PBC with autoimmune hepatitis (AIH) presents unique clinical challenges.
- Familial clustering of PBC suggests a genetic component, but environmental and immunological factors also play a role.
Observation:
- A mother and daughter both diagnosed with PBC exhibited significantly different clinical trajectories.
- The daughter, diagnosed with PBC-AIH overlap, succumbed to hepatic failure within seven months.
- The mother, diagnosed with PBC and alcoholic cirrhosis, showed no disease progression with treatment.
Findings:
- The daughter was positive for anti-glycoprotein 210 (anti-gp210) antibodies, while the mother was negative.
- This serological difference correlated with the disparate clinical outcomes observed in the familial cases.
- Anti-gp210 antibody status appears to be a significant prognostic factor in PBC.
Implications:
- The presence of anti-gp210 antibodies may predict a more aggressive course of PBC, irrespective of family history.
- This finding could influence risk stratification and treatment strategies for PBC patients.
- Further research into the role of anti-gp210 antibodies in PBC pathogenesis and prognosis is warranted.
Abstract:
A 30-year-old woman (daughter) was diagnosed to have primary biliary cholangitis (PBC) with autoimmune hepatitis (AIH) overlap syndrome. Although she was started on prednisolone and ursodeoxycholic acid (UA), she eventually died of hepatic failure with gastrointestinal hemorrhage seven months after the initial hospitalization. A 60-year-old woman (mother) was diagnosed with PBC with alcoholic liver cirrhosis, was treated with UA, and had no disease progression. These familial PBC patients had different clinical courses. While the mother was negative for the anti-glycoprotein 210 (anti-gp210) antibody, the daughter was positive for the same. These findings suggest that anti-gp210 antibody positivity affects the prognosis of PBC, even in familial cases.
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...